e-Lung Computed Tomography Biomarker Stratifies Patients at Risk of Idiopathic Pulmonary Fibrosis Progression in a 52-Week Clinical Trial.

Devaraj A, Ottink F, Rennison-Jones C, Blé FX, Joly O, Azim A, Gerry S, Harston G, Ostridge K, George PM

DOI: 10.1164/rccm.202312-2274le
Published: 2024 May 1
Container: American journal of respiratory and critical care medicine
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1164/rccm.202312-2274le,
  title = {e-Lung Computed Tomography Biomarker Stratifies Patients at Risk of Idiopathic Pulmonary Fibrosis Progression in a 52-Week Clinical Trial.},
  author = {Devaraj A and Ottink F and Rennison-Jones C and Blé FX and Joly O and Azim A and Gerry S and Harston G and Ostridge K and George PM},
  year = {2024},
  journal = {American journal of respiratory and critical care medicine},
  doi = {10.1164/rccm.202312-2274le},
  url = {https://doi.org/10.1164/rccm.202312-2274le}
}

RIS

TY  - JOUR
TI  - e-Lung Computed Tomography Biomarker Stratifies Patients at Risk of Idiopathic Pulmonary Fibrosis Progression in a 52-Week Clinical Trial.
AU  - Devaraj A
AU  - Ottink F
AU  - Rennison-Jones C
AU  - Blé FX
AU  - Joly O
AU  - Azim A
AU  - Gerry S
AU  - Harston G
AU  - Ostridge K
AU  - George PM
PY  - 2024
JO  - American journal of respiratory and critical care medicine
DO  - 10.1164/rccm.202312-2274le
UR  - https://doi.org/10.1164/rccm.202312-2274le
ER  -

APA

A, D., F, O., C, R., FX, B., O, J., A, A., S, G., G, H., K, O., & PM, G. (2024). e-Lung Computed Tomography Biomarker Stratifies Patients at Risk of Idiopathic Pulmonary Fibrosis Progression in a 52-Week Clinical Trial.. American journal of respiratory and critical care medicine. https://doi.org/10.1164/rccm.202312-2274le

Source records

pubmed · retrieved 2026-09-25T17:20:38.808Z
europe-pmc · retrieved 2026-09-25T17:20:38.825Z